Filed: 2/13/2023ACC: 0001214659-23-002122
📋 What this filing means
SIO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 46 equity positions with a total reported market value of $270.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
46
Positions
$270.39M
Total AUM (reported)
22M
Total Shares
Allocation by class
COM$164.37M60.8%
CL A SHS$23.39M8.7%
SPONSORED ADS$20.23M7.5%
SHS$16.63M6.2%
COMMON STOCK$16.42M6.1%
COM NEW$7.84M2.9%
COM PAR $0.01$7.63M2.8%
Portfolio Concentration
Top 3$106.78M39.5%
4–10$95.09M35.2%
11–25$53.73M19.9%
Rest$14.80M5.5%
Top 3 weight
39.5%
Top 10 weight
74.7%
Voting Authority Distribution
Total shares with voting rights: 22M
Sole
Full voting authority
22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole45
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings46
Rows:
PROMETHEUS BIOSCIENCES INC
SOLEShares574.20K
TypeSH
Market value$63.16M
23.36%
Sole
574.20K
Shared
0.00
None
0.00
MEDICUS SCIENCES ACQUISITION
DFNDShares2.32M
TypeSH
Market value$23.39M
8.65%
Sole
2.32M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares683.42K
TypeSH
Market value$20.23M
7.48%
Sole
683.42K
Shared
0.00
None
0.00
CIGNA CORP
SOLEShares52.61K
TypeSH
Market value$17.43M
6.45%
Sole
52.61K
Shared
0.00
None
0.00
ORGANON & CO
SOLEShares587.84K
TypeSH
Market value$16.42M
6.07%
Sole
587.84K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares54.96K
TypeSH
Market value$15.28M
5.65%
Sole
54.96K
Shared
0.00
None
0.00
QUEST DIAGNOSTICS INC
SOLEShares92K
TypeSH
Market value$14.39M
5.32%
Sole
92K
Shared
0.00
None
0.00
AMERISOURCEBERGEN CORP
SOLEShares84.40K
TypeSH
Market value$13.99M
5.17%
Sole
84.40K
Shared
0.00
None
0.00
MEDTRONIC PLC
SOLEShares128K
TypeSH
Market value$9.95M
3.68%
Sole
128K
Shared
0.00
None
0.00
STAAR SURGICAL CO
SOLEShares157.13K
TypeSH
Market value$7.63M
2.82%
Sole
157.13K
Shared
0.00
None
0.00
ICON PLC
SOLEShares33.98K
TypeSH
Market value$6.60M
2.44%
Sole
33.98K
Shared
0.00
None
0.00
INOGEN INC
SOLEShares286.69K
TypeSH
Market value$5.65M
2.09%
Sole
286.69K
Shared
0.00
None
0.00
AVANTOR INC
SOLEShares250K
TypeSH
Market value$5.27M
1.95%
Sole
250K
Shared
0.00
None
0.00
HESKA CORP
SOLEShares84.31K
TypeSH
Market value$5.24M
1.94%
Sole
84.31K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares434.63K
TypeSH
Market value$4.74M
1.75%
Sole
434.63K
Shared
0.00
None
0.00
NOVAVAX INC
SOLEShares340K
TypeSH
Market value$3.50M
1.29%
Sole
340K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares555.61K
TypeSH
Market value$3.48M
1.29%
Sole
555.61K
Shared
0.00
None
0.00
PHARVARIS NV
SOLEShares285K
TypeSH
Market value$3.21M
1.19%
Sole
285K
Shared
0.00
None
0.00
MERRIMACK PHARMACEUTICALS INC
SOLEShares250K
TypeSH
Market value$2.87M
1.06%
Sole
250K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares67K
TypeSH
Market value$2.55M
0.94%
Sole
67K
Shared
0.00
None
0.00
HEALTH SCIENCES ACQUISITIONS CORP 2
SOLEShares250K
TypeSH
Market value$2.50M
0.92%
Sole
250K
Shared
0.00
None
0.00
EUCRATES BIOMEDICAL ACQUISITION CORP.
SOLEShares248.67K
TypeSH
Market value$2.48M
0.92%
Sole
248.67K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares330K
TypeSH
Market value$1.98M
0.73%
Sole
330K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares86.40K
TypeSH
Market value$1.85M
0.68%
Sole
86.40K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares1.83M
TypeSH
Market value$1.81M
0.67%
Sole
1.83M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PROMETHEUS BIOSCIENCES INCSOLE | COM | 574.20K | SH | $63.16M 23.36% | 574.20K | 0.00 | 0.00 |
MEDICUS SCIENCES ACQUISITIONDFND | CL A SHS | 2.32M | SH | $23.39M 8.65% | 2.32M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 683.42K | SH | $20.23M 7.48% | 683.42K | 0.00 | 0.00 |
CIGNA CORPSOLE | COM | 52.61K | SH | $17.43M 6.45% | 52.61K | 0.00 | 0.00 |
ORGANON & COSOLE | COMMON STOCK | 587.84K | SH | $16.42M 6.07% | 587.84K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 54.96K | SH | $15.28M 5.65% | 54.96K | 0.00 | 0.00 |
QUEST DIAGNOSTICS INCSOLE | COM | 92K | SH | $14.39M 5.32% | 92K | 0.00 | 0.00 |
AMERISOURCEBERGEN CORPSOLE | COM | 84.40K | SH | $13.99M 5.17% | 84.40K | 0.00 | 0.00 |
MEDTRONIC PLCSOLE | SHS | 128K | SH | $9.95M 3.68% | 128K | 0.00 | 0.00 |
STAAR SURGICAL COSOLE | COM PAR $0.01 | 157.13K | SH | $7.63M 2.82% | 157.13K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 33.98K | SH | $6.60M 2.44% | 33.98K | 0.00 | 0.00 |
INOGEN INCSOLE | COM | 286.69K | SH | $5.65M 2.09% | 286.69K | 0.00 | 0.00 |
AVANTOR INCSOLE | COM | 250K | SH | $5.27M 1.95% | 250K | 0.00 | 0.00 |
HESKA CORPSOLE | COM RESTRC NEW | 84.31K | SH | $5.24M 1.94% | 84.31K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 434.63K | SH | $4.74M 1.75% | 434.63K | 0.00 | 0.00 |
NOVAVAX INCSOLE | COM NEW | 340K | SH | $3.50M 1.29% | 340K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 555.61K | SH | $3.48M 1.29% | 555.61K | 0.00 | 0.00 |
PHARVARIS NVSOLE | COM | 285K | SH | $3.21M 1.19% | 285K | 0.00 | 0.00 |
MERRIMACK PHARMACEUTICALS INCSOLE | COM NEW | 250K | SH | $2.87M 1.06% | 250K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 67K | SH | $2.55M 0.94% | 67K | 0.00 | 0.00 |
HEALTH SCIENCES ACQUISITIONS CORP 2SOLE | ORD SHS | 250K | SH | $2.50M 0.92% | 250K | 0.00 | 0.00 |
EUCRATES BIOMEDICAL ACQUISITION CORP.SOLE | UNIT 10/23/2027 | 248.67K | SH | $2.48M 0.92% | 248.67K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 330K | SH | $1.98M 0.73% | 330K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 86.40K | SH | $1.85M 0.68% | 86.40K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 1.83M | SH | $1.81M 0.67% | 1.83M | 0.00 | 0.00 |
Page 1 of 2